№ lp_2_3_36338
File format: docx
Character count: 8178
File size: 393 KB
Year:
2024
Region / city:
Norfolk and Norwich University Hospital
Subject:
Acute Renal Colic Pathway
Document Type:
Clinical Guideline
Organization / Institution:
Radiology Department
Author:
Consultant Radiologist
Target Audience:
General Practitioners
Period of Validity:
Until 19th October 2025
Approval Date:
19th October 2024
Date of Changes:
Not specified
Date of Review:
19th October 2025
Implementation Date:
N/A
Version:
1.0
Date:
05/2024
Reason for Change:
To originate document
Reference Number:
23626
Glossary:
CT, ED, EIA, GP, SDEC, SpR
Consulted:
Consultant Radiologists, Imaging Services Manager, Imaging Support Services Manager, CT Lead Radiographers, Radiology Operation Managers, Urology SpR
Responsibilities:
General Practitioner, Radiologist, Urology SpR, Radiographer, Radiology Receptionist, Radiology Bookings team, Emergency Department
Eligibility Criteria:
Acute unilateral loin pain, aged 18-80
Context:
A clinical guideline for managing acute renal colic cases in General Practitioners and related imaging processes at the Norfolk and Norwich University Hospital.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2010
Region / City:
Not specified
Theme:
Radiology, Acute Renal Colic, Imaging, Diagnostic Yield
Document Type:
Audit
Institution:
Not specified
Target Audience:
Medical professionals, Radiologists, Urologists
Period of Effect:
Not specified
Approval Date:
19 February 2010
Date of Last Review:
18 February 2021
Year:
2025
Region:
England
Subject:
Hepatitis B vaccination for renal patients
Document Type:
Patient Group Direction (PGD)
Authorising Organisation:
UK Health Security Agency (UKHSA)
Target Audience:
Registered healthcare professionals
Period of Validity:
28 February 2025 - 28 February 2028
Approval Date:
28 February 2025
Amendment Date:
21 February 2025
Year:
2023
Region / City:
Canberra
Topic:
Continuous Renal Replacement Therapy
Document Type:
Procedure
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical Officers, Nurses, Midwives, Physiotherapists, Students under direct supervision
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Version:
4.2.1.0
Protocol Posting Date:
June 2025
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2026
Year:
2025
Region / City:
Not specified
Subject:
Renal cell carcinoma, nephrectomy, tumor classification
Document Type:
Protocol
Institution:
CAP (College of American Pathologists)
Author:
Paari Murugan, MD, FCAP*, Robert W. Allan, MD, FCAP*, Lara R. Harik, MD, FCAP*
Target Audience:
Pathologists, medical professionals involved in cancer diagnostics
Effective Period:
March 2026 onward
Approval Date:
June 2025
Revision Date:
Not specified
Note:
Qualifications
Year:
2010
Region / City:
Not specified
Theme:
Radiology, Acute Renal Colic, Imaging, Diagnostic Yield
Document Type:
Audit
Institution:
Not specified
Target Audience:
Medical professionals, Radiologists, Urologists
Period of Effect:
Not specified
Approval Date:
19 February 2010
Date of Last Review:
18 February 2021
Note:
Year
Context:
Criteria for entry into the ST4 Renal Medicine program in the UK, outlining essential qualifications, eligibility requirements, career progression, and clinical experience.
Type of document:
Case report
Journal:
PJKD
Year:
2024
Volume and issue:
8(1)
DOI:
Not specified
Received:
April 26, 2023
Accepted:
October 27, 2023
Authors:
Sajid Islam Bhatti; Tajammul Waqar; Shafique Younus; Sidra German
Corresponding author:
Sajid Islam Bhatti
Author affiliation:
Department of Nephrology, Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan
Country:
Pakistan
Clinical setting:
Sindh Institute of Urology and Transplantation (SIUT), Karachi
Subject area:
Nephrology
Keywords:
Mixed essential cryoglobulinemia; mesangiocapillary glomerulonephritis; HCV; purpura; vasculitis
Patient profile:
52-year-old male
Study focus:
Renal involvement in mixed essential cryoglobulinemia
Diagnostic methods:
Renal biopsy; immunofluorescence; serology; complement levels; imaging studies
Treatment:
Prednisolone; mycophenolate mofetil; cyclophosphamide
Number of patients:
80
Setting:
Intensive care unit
Procedure:
Transvenous renal biopsy
Study design:
Observational analytical study
Statistical methods:
Student’s t-test; Wilcoxon’s rank test; χ2 test; logistic regression with backward-stepwise variable elimination
Outcomes assessed:
Composite complication endpoint; acute tubular necrosis diagnosis; diagnostic yield; in-ICU mortality; therapeutic consequences
Variables analyzed:
Demographic characteristics; clinical scores (SOFA, SAPS II); laboratory parameters; anticoagulation and antiplatelet therapy; bleeding-risk factors; vasopressor use; mechanical ventilation; extracorporeal membrane oxygenation
Time comparison:
TVRB performed before 2012 vs after 2012; biopsy after 2015
Therapeutic interventions evaluated:
Corticosteroids; cyclophosphamide; plasmapheresis; intravenous immunoglobulins; rituximab; eculizumab; calcineurin inhibitors; anticoagulation
Definition of composite endpoint:
Renal hematoma; macroscopic hematuria; transfusion during days 1–3 post-TVRB; SOFA score increase ≥1 point from TVRB day to day +3; hemoglobin decrease ≤ –2 g/dL from TVRB day to day +3
Year:
2013
Region / City:
Leeds, Yorkshire and The Humber
Theme:
Clinical trials, Chronic Kidney Disease
Document type:
Research study protocol
Organization:
University of Birmingham Clinical Trials Unit, Hull and East Yorkshire Hospitals NHS Trust
Author:
Prof Sunil Bhandari
Target audience:
Healthcare professionals, nephrologists, researchers
Period of validity:
3 years
Approval date:
2013
Change date:
N/A
Study reference number:
11/30/07
Ethics committee reference:
13/YH/0394
EudraCT number:
2013-003798-82
Sponsor:
Hull and East Yorkshire Hospitals NHS Trust
Funding source:
Efficacy and Mechanism Evaluation (EME) programme, National Institute for Health Research (NIHR), Medical Research Council (MRC)
Note:
Contextual description
Year:
2010-2024
Region / city:
Asia-Pacific
Subject:
Hepatology
Document Type:
Clinical Practice Guidelines
Organization / Institution:
Asian Pacific Association for the Study of the Liver (APASL)
Author:
APASL
Target Audience:
Healthcare professionals
Period of validity:
2010-2024
Date of approval:
2010
Date of revisions:
2024
Context:
Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Year:
2022
Institution:
Towson University
Author:
Laura Sessions PhD, MScN, RN, CNE
Topic:
End Stage Renal Disease, Dialysis, Peritonitis
Document Type:
Case Study
Target Audience:
Nursing students, healthcare professionals
Case Study Link:
https://umaryland.az1.qualtrics.com/jfe/form/SV_d76sxmjHW6XOqTc
Bow-tie Link:
https://umaryland.az1.qualtrics.com/jfe/form/SV_8239FzxAw851hzw
Date of Case:
September 1, 2022
Year:
2019
Region / city:
Malaysia
Topic:
Pharmacokinetics, Vancomycin, Critical Care, Renal Replacement Therapy
Document Type:
Research Study
Institution:
Universiti Teknologi MARA, University of Malaya, Hospital Tengku Ampuan Afzan
Author:
Janattul-Ain Jamal, Helmi Sulaiman, Fariz-Safhan Mohamad-Nor, Norkasihan Ibrahim, Ahmad Fauzi Dali, Mohd-Hafiz Abdul-Aziz
Target Audience:
Healthcare professionals, researchers
Period of Effect:
Not specified
Approval Date:
2019
Date of Changes:
Not specified
Year:
2023
Region / City:
Ohio, USA
Topic:
Nanotechnology, RNA Nanoparticles, Cancer Targeting
Document Type:
Research Article
Organization / Institution:
The Ohio State University, Wexner Medical Center
Author:
Hongzhi Wang, Chiran Ghimire, Hui Li, Mario Vieweger, Congcong Xu, Peixuan Guo
Target Audience:
Researchers, Scientists, Medical Professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Context
Year:
2026
Region / city:
Not specified
Topic:
Renal system diseases, Urinary tract disorders
Document type:
Educational material
Institution:
Not specified
Author:
Not specified
Target audience:
Medical students, healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Organisation:
Canberra Health Services
Region:
Canberra, Australian Capital Territory, Australia
Healthcare setting:
Hospital in the Home
Clinical area:
Cardiology
Condition:
Congestive cardiac failure
Patient population:
Adults
Type of document:
Clinical procedure
Route of administration:
Intravenous
Treatment:
Furosemide
Admission criteria:
Defined clinical and general eligibility requirements
Source type:
Institutional clinical guideline
Document type:
Memorandum
Request type:
Non-substantive change request
Subject:
Acute Respiratory Illness reporting for cruise ships
Program:
Phased Approach to the Resumption of Cruise Ship Passenger Operations
OMB Control Number:
0920-1335
OMB expiration date:
January 31, 2026
Issuing organization:
Centers for Disease Control and Prevention
Division:
National Center for Emerging and Zoonotic Infectious Diseases
Program contact:
Rudith Vice
Contact address:
1600 Clifton Road, NE, Atlanta, Georgia 30333
Contact phone:
404-718-7292
Contact email:
[email protected]
Date of document:
October 23, 2023
Effective date of proposed changes:
Upon receipt of OMB approval
Geographic scope:
United States
Regulatory reference:
42 CFR part 71
Target respondents:
Cruise ship physicians
Reporting system:
REDCap
Related attachment:
Attachment H_10202023
Year:
2027
Region / City:
United States
Topic:
Healthcare Technology, Medical Devices
Document Type:
Tracking Form
Agency / Organization:
Centers for Medicare & Medicaid Services
Author:
Unknown
Target Audience:
Healthcare Providers, Medical Device Manufacturers
Effective Period:
Fiscal Year 2027
Approval Date:
Unknown
Date of Changes:
Unknown
Acute Inpatient Psychiatric Admission Form for Patients Aged 10–17 with Neurodevelopmental Disorders
Patient Name:
____________________________________________
Date of Birth:
____________________
Home Address:
_________________________________________________________________________
Parent/Guardian Name/Phone/Email:
______________________________________________________
Expected Admission Type:
Voluntary / Involuntary
Referral for:
Acute Inpatient Psychiatric Treatment, approximately 30 days
Target Population:
Patients aged 10–17 with autism spectrum disorder, intellectual disability, or related neurodevelopmental disability
Current Psychiatric Provider:
UNC Psychiatry Outpatient (if applicable)
Diagnoses:
_____________________________________________________________________________
Current Medications:
____________________________________________________________________
Medical Problems:
______________________________________________________________________
Isolation Precautions:
No / Yes
Past Medical Hospitalizations or Surgeries:
__________________________________________________
Previous Psychiatric Treatment:
___________________________________________________________
Substance Use:
_________________________________________________________________________
Post-Treatment Residence Confirmed:
No / Yes
Department of Social Services / Child Protective Services Involvement:
_________________________
Consent for Medical Treatment:
___________________________________________________________
Last COVID Test:
___________________
Laboratory Results:
Within normal limits / Not done / Any abnormalities: ______________________
Pregnancy Status:
No / Yes
Seizure History:
No / Yes, well-controlled / Yes, uncontrolled
Last Vital Signs:
T______ P______ BP______ RR______ O2 Sat _____ Weight______ Height_______ BMI_________
Pending/Past Legal Problems:
_____________________________________________________________
ADL Support:
Independent / Needs Assistance with Eating, Hygiene, Walking (specify assist device)
Communication Method:
Verbally (sentences/words/phrases), Sign language, Pictures, Device, Gestures
Sensory Needs:
Hearing impaired / Visually impaired / Over/undersensitive to ____________________